89 related articles for article (PubMed ID: 30486825)
1. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection.
Ma XL; Gao XH; Gong ZJ; Wu J; Tian L; Zhang CY; Zhou Y; Sun YF; Hu B; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
Oncotarget; 2016 Oct; 7(43):70654-70668. PubMed ID: 27683106
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.
Meischl T; Rasoul-Rockenschaub S; Györi G; Sieghart W; Reiberger T; Trauner M; Soliman T; Berlakovich G; Pinter M
PLoS One; 2019; 14(5):e0216677. PubMed ID: 31141535
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis.
Xiao B; Ouyang H; Gulizeba H; Fu H; Wang Z; Huang Y
Cancer Immunol Immunother; 2023 Nov; 72(11):3683-3692. PubMed ID: 37589756
[TBL] [Abstract][Full Text] [Related]
6. Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Guan R; Mei J; Lin W; Deng M; Li S; Guo R
Hepatol Int; 2023 Oct; 17(5):1279-1288. PubMed ID: 37129721
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.
Wang Y; Wang ZQ; Wang FH; Lei XF; Yan SM; Wang DS; Zhang F; Xu RH; Wang LY; Li YH
Oncotarget; 2016 Aug; 7(35):57290-57300. PubMed ID: 27344180
[TBL] [Abstract][Full Text] [Related]
8. HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.
Morris JS; Hassan MM; Zohner YE; Wang Z; Xiao L; Rashid A; Haque A; Abdel-Wahab R; Mohamed YI; Ballard KL; Wolff RA; George B; Li L; Allen G; Weylandt M; Li D; Wang W; Raghav K; Yao J; Amin HM; Kaseb AO
Hepatology; 2021 Jun; 73(6):2278-2292. PubMed ID: 32931023
[TBL] [Abstract][Full Text] [Related]
9. Identification and verification of novel ferroptosis biomarkers predicts the prognosis of hepatocellular carcinoma.
Wu S; Liu M; Xiao S; Lai M; Wei L; Li D; Wang L; Yin F; Zeng X
Genomics; 2023 Nov; 115(6):110733. PubMed ID: 37866659
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy.
Xiao BJ; Sima XX; Chen G; Gulizeba H; Zhou T; Huang Y
Cancer Med; 2023 Aug; 12(16):16918-16928. PubMed ID: 37409613
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence-based reticulin proportionate area - a novel histological outcome predictor in hepatocellular carcinoma.
Patil A; Salvatori R; Smith L; Jenkins SM; Cannon A; Hartley CP; Graham RP; Moreira RK
Histopathology; 2023 Oct; 83(4):512-525. PubMed ID: 37387193
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
Andersen HH; Bojesen SE; Johansen JS; Ejlertsen B; Berg T; Tuxen M; Madsen K; Danø H; Flyger H; Jensen MB; Nielsen DL
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):662-670. PubMed ID: 38358318
[TBL] [Abstract][Full Text] [Related]
13. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts.
Gwenzi T; Schrotz-King P; Anker SC; Schöttker B; Hoffmeister M; Brenner H
ESMO Open; 2024 Apr; 9(4):102982. PubMed ID: 38613909
[TBL] [Abstract][Full Text] [Related]
14. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y; Li L; Xu Y; Ouyang J; Zhou Y; Ye F; Huang Z; Zhang W; Zhou A; Zhao X; Cai J; Wang Y; Zhou J; Zhao H
Radiol Med; 2024 Feb; 129(2):188-201. PubMed ID: 38180570
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
16. Circulating sNinj1 as a novel predictor of prognosis and severity in hepatocellular carcinoma.
Yan L; Su W; Gan D; Li D; Mai L; Wang B; Wang L; Peng L; Jiang L; Wang Z; Hu Q; Chen W
Clin Chim Acta; 2023 Oct; 550():117581. PubMed ID: 37802206
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Chamseddine S; Mohamed YI; Lee SS; Yao JC; Hu ZI; Tran Cao HS; Xiao L; Sun R; Morris JS; Hatia RI; Hassan M; Duda DG; Diab M; Mohamed A; Nassar A; Datar S; Amin HM; Kaseb AO
Oncology; 2023; 101(11):730-737. PubMed ID: 37467732
[TBL] [Abstract][Full Text] [Related]
18. Pathological overview of steatohepatitic hepatocellular carcinoma in a surgical series.
Trapani L; Beaufrère A; Hobeika C; Codjia T; Albuquerque M; Bouattour M; Lesurtel M; Cauchy F; Paradis V
Histopathology; 2023 Oct; 83(4):526-537. PubMed ID: 37222200
[TBL] [Abstract][Full Text] [Related]
19. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors.
Shrotriya S; Walsh D; Nowacki AS; Lorton C; Aktas A; Hullihen B; Benanni-Baiti N; Hauser K; Ayvaz S; Estfan B
PLoS One; 2018; 13(8):e0202555. PubMed ID: 30138391
[TBL] [Abstract][Full Text] [Related]
20. Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study.
Liu ZY; Yishake D; Fang AP; Zhang DM; Liao GC; Tan XY; Zhang YJ; Zhu HL
Nutr Metab (Lond); 2020; 17():25. PubMed ID: 32256673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
